Shanghai Henlius Biotech (HKG:2696) Full Year 2023 ResultsKey Financial Results Revenue: CN¥5.39b (up 68% from FY 2022). Net income: CN¥546.0m (up from CN¥695.3m loss in FY 2022). Profit margin: 10% (...
Source LinkShanghai Henlius Biotech (HKG:2696) Full Year 2023 ResultsKey Financial Results Revenue: CN¥5.39b (up 68% from FY 2022). Net income: CN¥546.0m (up from CN¥695.3m loss in FY 2022). Profit margin: 10% (...
Source Link
Comments